Carol Duffy - Virios Therapeutics Chief Advisor
| VIRIDelisted Stock | USD 3.95 0.00 0.00% |
Insider
Carol Duffy is Chief Advisor of Virios Therapeutics Llc
| Phone | 866 620 8655 |
| Web | https://www.virios.com |
Virios Therapeutics Management Efficiency
The company has return on total asset (ROA) of (0.6776) % which means that it has lost $0.6776 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1956) %, meaning that it created substantial loss on money invested by shareholders. Virios Therapeutics' management efficiency ratios could be used to measure how well Virios Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Virios Therapeutics Llc currently holds 358.55 K in liabilities. Virios Therapeutics Llc has a current ratio of 4.66, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Virios Therapeutics' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Anna Moore | Transcode Therapeutics | 62 | |
| Robert Dudley | Transcode Therapeutics | 73 | |
| Nandan BS | Immix Biopharma | 62 | |
| JD MBA | Immix Biopharma | N/A | |
| Samuel MD | Altamira Therapeutics | 71 | |
| Covadonga Paeda | Altamira Therapeutics | N/A | |
| DSc MSE | Immix Biopharma | 75 | |
| Carol Odle | Revelation Biosciences | N/A | |
| Marcel CPA | Altamira Therapeutics | 66 | |
| MBA MD | Immix Biopharma | 49 | |
| Karen Cashmere | ZyVersa Therapeutics | 72 | |
| Jay Cross | Sonnet Biotherapeutics Holdings | 53 | |
| CPA CTP | Cns Pharmaceuticals | 44 | |
| Jean Lechance | Altamira Therapeutics | N/A | |
| Susan Dexter | Sonnet Biotherapeutics Holdings | 69 | |
| Qiyong Liu | Transcode Therapeutics | 60 | |
| Manuel Dafonseca | Sonnet Biotherapeutics Holdings | N/A | |
| James Rolke | Revelation Biosciences | 55 | |
| Chester III | Revelation Biosciences | 44 | |
| LaBella MS | ZyVersa Therapeutics | 66 | |
| Waldemar Priebe | Cns Pharmaceuticals | N/A | |
Management Performance
| Return On Equity | -1.2 | |||
| Return On Asset | -0.68 |
Virios Therapeutics Llc Leadership Team
Elected by the shareholders, the Virios Therapeutics' board of directors comprises two types of representatives: Virios Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Virios. The board's role is to monitor Virios Therapeutics' management team and ensure that shareholders' interests are well served. Virios Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Virios Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gregory Duncan, Chairman CEO | ||
| Carol Duffy, Chief Advisor | ||
| William MD, Founder Director | ||
| Ralph MPH, Senior Operations | ||
| Angela Walsh, SVP CFO |
Virios Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Virios Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.2 | |||
| Return On Asset | -0.68 | |||
| Current Valuation | 1.28 M | |||
| Shares Outstanding | 1.11 M | |||
| Shares Owned By Insiders | 6.74 % | |||
| Shares Owned By Institutions | 3.60 % | |||
| Number Of Shares Shorted | 469.93 K | |||
| Price To Book | 1.37 X | |||
| EBITDA | 150.9 K | |||
| Net Income | (5.3 M) |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in Virios Stock
If you are still planning to invest in Virios Therapeutics Llc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Virios Therapeutics' history and understand the potential risks before investing.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |